| Serial Number | 88751602 |
| Word Mark | IMMUVANCE |
| Filing Date | Wednesday, January 8, 2020 |
| Status | 605 - ABANDONED - EXPRESS AFTER PUB |
| Status Date | Friday, June 10, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 28, 2020 |
| Goods and Services | therapeutic preparations, namely, antibodies for use in targeting the CCR5 cell receptor; therapeutic preparations for the treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; therapeutic preparations for the prevention of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19 |
| Goods and Services | providing a website featuring medical information; providing a website featuring information in the field of antibodies for use in targeting the CCR5 cell receptor; providing health and medical information, namely, providing a website featuring information in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; all of the forgoing excluding information directed to adjuvants for vaccines and molecular genetics and genomics testing and reporting |
| Goods and Services | scientific research consulting services in the field of immunology; scientific research consulting services in the field of antibodies for use in targeting the CCR5 cell receptor; scientific research consulting services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; medical research services; medical research services in the field of antibodies for use in targeting the CCR5 cell receptor; medical research services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; all of the foregoing excluding medical research and scientific research consulting services directed to adjuvants for vaccines and molecular genetics and genomics testing and reporting |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Friday, June 10, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Friday, June 10, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Friday, June 10, 2022 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | CytoDyn Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Vancouver, WA 98660 |
| Party Name | CytoDyn Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Vancouver, WA 98660 |
| Event Date | Event Description |
| Friday, June 10, 2022 | ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION |
| Friday, June 10, 2022 | ABANDONMENT - AFTER PUBLICATION |
| Thursday, June 9, 2022 | TEAS EXPRESS ABANDONMENT RECEIVED |
| Thursday, March 24, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, March 22, 2022 | SOU EXTENSION 3 GRANTED |
| Tuesday, March 22, 2022 | SOU EXTENSION 3 FILED |
| Tuesday, March 22, 2022 | TEAS EXTENSION RECEIVED |
| Saturday, August 14, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, August 12, 2021 | SOU EXTENSION 2 GRANTED |
| Thursday, August 12, 2021 | SOU EXTENSION 2 FILED |
| Thursday, August 12, 2021 | TEAS EXTENSION RECEIVED |
| Friday, March 19, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, March 17, 2021 | SOU EXTENSION 1 GRANTED |
| Wednesday, March 17, 2021 | SOU EXTENSION 1 FILED |
| Wednesday, March 17, 2021 | TEAS EXTENSION RECEIVED |
| Tuesday, September 22, 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, July 28, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 28, 2020 | PUBLISHED FOR OPPOSITION |
| Wednesday, July 8, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, June 24, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, June 24, 2020 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, June 24, 2020 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, June 24, 2020 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, June 24, 2020 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, June 23, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, June 22, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, June 22, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, March 27, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, March 27, 2020 | NON-FINAL ACTION E-MAILED |
| Friday, March 27, 2020 | NON-FINAL ACTION WRITTEN |
| Thursday, March 26, 2020 | ASSIGNED TO EXAMINER |
| Monday, January 13, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Saturday, January 11, 2020 | NEW APPLICATION ENTERED IN TRAM |